Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
Clicks: 103
ID: 280539
2022
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
103 views
24 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #48 of 54 articles by views in Life sciences
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Since the very beginning of the coronavirus disease 2019 (COVID-19) pandemic in early 2020, it was evident that patients with cardiovascular disease (CVD) were at an increased risk of developing severe illness, and complications spanning cerebrovascular disorders, dysrhythmias, acute coronary syndrome, ischemic and non-ischemic heart disease, pericarditis, myocarditis, heart failure, thromboembolic disease, stroke, and death. Underlying these was excessive systemic inflammation and coagulopathy due to SARS-COV-2 infection, the effects of which also continued long-term as evidenced by post-COVID-19 cardiovascular complications. The acute and chronic cardiovascular effects of COVID-19 occurred even among those who were not hospitalized and had no previous CVD or those with mild symptoms. This comprehensive review summarizes the current understanding of molecular mechanisms triggered by the SARS-CoV-2 virus on various cells that express the angiotensin-converting enzyme 2, leading to endothelial dysfunction, inflammation, myocarditis, impaired coagulation, myocardial infarction, arrhythmia and a multisystem inflammatory syndrome in children or Kawasaki-like disease.
| Reference Key |
aleksova2022longtermlife
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Aleksova, Aneta;Fluca, Alessandra Lucia;Gagno, Giulia;Pierri, Alessandro;Padoan, Laura;Derin, Agnese;Moretti, Rita;Noveska, Elena Aleksova;Azzalini, Eros;D'Errico, Stefano;Beltrami, Antonio Paolo;Zumla, Alimuddin;Ippolito, Giuseppe;Sinagra, Gianfranco;Janjusevic, Milijana; |
| Journal | Life sciences |
| Year | 2022 |
| DOI |
10.1016/j.lfs.2022.121018
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.